Literature DB >> 12435430

Neurotrophin potentiation of iron-induced spinal cord injury.

J W Mcdonald1, V G Stefovska, X Z Liu, H Shin, S Liu, D W Choi.   

Abstract

Previous studies have shown that pretreatment with neurotrophins can potentiate the vulnerability of cultured neurons to excitotoxic and free radical-induced necrosis, in contrast to their well known neuroprotective effects against apoptosis. Here we tested the hypothesis that this unexpected injury-potentiating effect of neurotrophins would also take place in the adult rat spinal cord. Fe(3+)-citrate was injected stereotaxically into spinal cord gray matter in adult rats in amounts sufficient to produce minimal tissue injury 24 h later. Twenty-four-hour pretreatment with brain-derived neurotrophic factor, neurotrophin-3, or neurotrophin-4/5, but not nerve growth factor, markedly enhanced tissue injury in the gray matter as evidenced by an increase in the damaged area, as well as the loss of neurons and oligodendrocytes. Consistent with maintained free radical mediation, the neurotrophin-potentiated iron-induced spinal cord damage was blocked by co-application of the antioxidant N-tert-butyl-(2-sulfophenyl)-nitrone. These data support the hypothesis that the overall neuroprotective properties of neurotrophins in models of acute injury to the spinal cord may be limited by an underlying potentiation of free radical-mediated necrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435430     DOI: 10.1016/s0306-4522(02)00342-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

Review 1.  [Tissue engineering of erectile nerves].

Authors:  F May; N Weidner; K Matiasek; M Vroemen; T Mrva; C Caspers; J Henke; T Brill; A Lehmer; A Blesch; W Erhardt; B Gänsbacher; R Hartung
Journal:  Urologe A       Date:  2004-10       Impact factor: 0.639

2.  Exogenous BDNF rescues rat spiral ganglion neurons in vivo.

Authors:  Sarah L McGuinness; Robert K Shepherd
Journal:  Otol Neurotol       Date:  2005-09       Impact factor: 2.311

3.  Oligodendrocyte vulnerability following traumatic brain injury in rats.

Authors:  George Lotocki; Juan Pablo de Rivero Vaccari; Juan de Rivero Vaccari; Ofelia Alonso; Juliana Sanchez Molano; Ryan Nixon; Padideh Safavi; W Dalton Dietrich; Helen M Bramlett
Journal:  Neurosci Lett       Date:  2011-06-06       Impact factor: 3.046

4.  Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss.

Authors:  Robert K Shepherd; Anne Coco; Stephanie B Epp; Jeremy M Crook
Journal:  J Comp Neurol       Date:  2005-05-30       Impact factor: 3.215

5.  Identification of potentially neuroprotective genes upregulated by neurotrophin treatment of CA3 neurons in the injured brain.

Authors:  Saafan Z Malik; Shahab Motamedi; Nicolas C Royo; David LeBold; Deborah J Watson
Journal:  J Neurotrauma       Date:  2011-01-27       Impact factor: 5.269

6.  Role of MAPK/ERK in neurotrophin-4 potentiation of necrotic neuronal death.

Authors:  Doug Lobner; Geraldine Liot
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

7.  Intraspinal TLR4 activation promotes iron storage but does not protect neurons or oligodendrocytes from progressive iron-mediated damage.

Authors:  Evan Z Goldstein; Jamie S Church; Nicole Pukos; Manoj K Gottipati; Phillip G Popovich; Dana M McTigue
Journal:  Exp Neurol       Date:  2017-08-26       Impact factor: 5.330

8.  OLIGODENDROCYTE VULNERABILITY FOLLOWING TRAUMATIC BRAIN INJURY IN RATS: EFFECT OF MODERATE HYPOTHERMIA.

Authors:  George Lotocki; Juan de Rivero Vaccari; Ofelia Alonso; Juliana Sanchez Molano; Ryan Nixon; W Dalton Dietrich; Helen M Bramlett
Journal:  Ther Hypothermia Temp Manag       Date:  2011-04-05       Impact factor: 1.286

Review 9.  What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?

Authors:  Robert A Watson; Trevor M Yeung
Journal:  BMC Neurol       Date:  2011-09-23       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.